Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Oct;21(10):732-44.
doi: 10.1080/14767050802361807.

A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor

Offer Erez  1 , Jimmy Espinoza, Tinnakorn Chaiworapongsa, Francesca Gotsch, Juan Pedro Kusanovic, Nandor Gabor Than, Shali Mazaki-Tovi, Edi Vaisbuch, Zoltan Papp, Bo Hyun Yoon, Yu Mi Han, Debra Hoppensteadt, Jawed Fareed, Sonia S Hassan, Roberto Romero
Affiliations
Comparative Study

A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor

Offer Erez et al. J Matern Fetal Neonatal Med. 2008 Oct.

Abstract

Objective: Vaginal bleeding is a risk factor for preterm PROM (PPROM). A disorder of decidual hemostasis has been implicated in the genesis of PROM. Indeed, excessive thrombin generation has been demonstrated in PPROM both before and at the time of diagnosis. Decidua is a potent source of tissue factor (TF), the most powerful natural pro-coagulant. A decidual hemostatic disorder may link vaginal bleeding, PPROM and placental abruption. This study was conducted to determine the behaviour of maternal TF and its natural inhibitor, the tissue factor pathway inhibitor (TFPI) in PPROM.

Methods: This cross-sectional study included women with PPROM (n = 123) and women with normal pregnancies (n = 86). Plasma concentrations of TF and TFPI were measured by a sensitive immunoassay. Non-parametric statistics were used for analysis.

Results: (1) The median maternal plasma TF concentration was significantly higher in patients with PPROM than in women with normal pregnancies (median: 369.5 pg/mL; range: 3.27-2551 pg/mL vs. median: 291.5 pg/mL; range: 6.3-2662.2 pg/mL respectively, p = 0.001); (2) the median maternal TFPI plasma concentration was significantly lower in patients with PPROM than in women with normal pregnancies (median: 58.7 ng/mL; range: 26.3-116 ng/mL vs. median: 66.1 ng/mL; range: 14.3-86.5 ng/mL respectively, p = 0.019); (3) there was no correlation between the plasma concentration of TF and TFPI and the gestational age at sample collection; and (4) among patients with PPROM there was no association between the presence of intra-amniotic infection or inflammation and median plasma concentrations of TF and TFPI.

Conclusions: (1) Patients with PPROM have a higher median plasma concentration of TF and a lower median plasma concentration of TFPI than women with normal pregnancies. (2) These findings suggest that PPROM is associated with specific changes in the hemostatic/coagulation system.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The correlations between maternal plasma tissue factor (TF)(1a) and tissue factor pathway inhibitor (TFPI) (1b) concentrations and gestational age at blood collection.
Figure 2
Figure 2
Comparison of maternal plasma tissue factor (TF) concentrations between women with normal pregnancy (n=79) and patients with preterm PROM (n=123). Tissue factor plasma concentrations were significantly higher in patients with preterm PROM than in women with a normal pregnancy (median: 369.5 pg/ml; range: 3.27-2551 pg/ml vs. median: 291.5 pg/ml; range: 6.3-2662.2 pg/ml, respectively; p=0.001).
Figure 3
Figure 3
Comparison of maternal plasma tissue factor pathway inhibitor (TFPI) concentrations between women with normal pregnancy (n=86) and patients with preterm PROM (n=123). TFPI plasma concentrations were significantly lower in patients with preterm PROM than in women with a normal pregnancy (median: 58.7 ng/ml; range: 26.3-116 ng/ml vs. median: 66.1 ng/ml; range: 14.3-86.5 ng/ml, respectively; p=0.019).
See this image and copyright information in PMC

References

    1. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187:1137–1142. - PubMed
    1. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet.Gynecol. 1997;89:265–271. - PubMed
    1. Chaiworapongsa T, Espinoza J, Yoshimatsu J, Kim YM, Bujold E, Edwin S, Yoon BH, Romero R. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J.Matern.Fetal Neonatal Med. 2002;11:368–373. - PubMed
    1. Rosen T, Kuczynski E, O’Neill LM, Funai EF, Lockwood CJ. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J.Matern.Fetal Med. 2001;10:297–300. - PubMed
    1. Lockwood CJ, Toti P, Arcuri F, Paidas M, Buchwalder L, Krikun G, Schatz F. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol. 2005;167:1443–1449. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources